Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Inocucor Corporation Plans Headquarters & Commercialization Hub in Centennial, Colorado

07/27/2017
Inocucor Corporation, a developer and producer of powerful biological crop inputs for agriculture, will open its 30,000-square-foot United States headquarters and commercialization office at 7304 South Joliet Street in Centennial, Colorado.

The company uses a patented fermentation process to combine multi-strains of bacteria and yeasts into powerful soil and plant optimizers that are safe for people and the environment. These products naturally improve crop yields, shorten growing periods and create healthier, more resilient soils for farmers and greenhouse growers.

Inocucor’s move to Denver is supported by a performance-based Job Growth Incentive Tax Credit of $1,322,918 approved by Colorado's Economic Development Commission.

Concurrent with the Denver headquarters and production facility opening this fall, Inocucor will be doubling its existing 10,000-square-foot lab and offices in Montreal. The Montreal facility will become its Technical Center of Excellence for technology innovation, new-product development, fermentation process development and pilot production. This entity will continue to be called Inocucor Technologies Inc. and will remain its Canadian headquarters.

Inocucor currently employs approximately 30 people in Montreal and the United States. The company plans to add another 50 high-level scientific and managerial staff in both in its Montreal and Denver operations over the next 18 months.

"Inocucor is a leader in the emerging sector of specialty ag biologicals," said Inocucor's President & CEO Donald R. Marvin, a Denver resident. "We are one of a handful of companies that have successfully commercialized microbial crop inputs based on a microbial consortia technology that improve the plant microbiome, which translates into healthier soils and improved water quality. The result for the grower is improved crop yields and reduced need for pesticides and chemical fertilizers."

Marvin said Inocucor will grow organically with its patented proprietary microbial consortia technology while also pursuing strategic acquisitions and product development partnerships in North America, Latin America and Western Europe.

Share

Exclusive Research